Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Family Intervention for Mental Illness and Substance Abuse
This study is ongoing, but not recruiting participants.
Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00043693
  Purpose

This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.


Condition Intervention
Schizophrenia
Bipolar Disorder
Substance-Related Disorders
Behavioral: Family Intervention for Dual Diagnosis
Behavioral: Family psychoeducation program

MedlinePlus related topics: Bipolar Disorder Dual Diagnosis Mental Health Schizophrenia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Family Intervention for SMI and Substance Use Disorder

Further study details as provided by National Institute of Mental Health (NIMH):

Primary Outcome Measures:
  • Alcohol use scale-revised [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Drug use scale-revised [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Substance abuse treatment scale [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]
  • Timeline followback calandar [ Time Frame: Measured at baseline, during treatment, and post-treatment ] [ Designated as safety issue: No ]

Estimated Enrollment: 140
Study Start Date: April 2002
Estimated Study Completion Date: January 2009
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Participants will undergo the Family Intervention for Dual Diagnosis (FIDD) program.
Behavioral: Family Intervention for Dual Diagnosis
The family intervention for dual diagnosis program lasts for up to 3 years and includes both single and multiple-family group formats.
2: Active Comparator
Participants will be placed in a family psychoeducation program.
Behavioral: Family psychoeducation program
The family psychoeducation program consists of 6 weekly sessions.

Detailed Description:

Substance use disorder (SUD) in persons with severe mental illness may worsen the course of psychiatric illness. The loss of family support for individuals with mental illness is a major contributing factor to housing instability, homelessness, and other problems. Despite progress toward integrating mental health and substance abuse services, interventions that improve the course of mental illness while helping the families of the mentally ill are not currently available. Enhancing skills for coping with mental illness may be an effective strategy for treating SUD, decreasing caregiver burden, and improving the long-term outcomes for people with mental illness.

Patients and their families are randomly assigned to either the Family Intervention for Dual Diagnosis (FIDD) program or family psychoeducation. The FIDD program lasts for up to 3 years and includes both single and multiple-family group formats. The family psychoeducation program consists of 6 weekly sessions. Routine assessments are conducted on all patients, and relatives are evaluated on a wide range of outcomes, including substance abuse, hospitalizations, psychiatric symptoms, legal problems, aggression, housing and homelessness, family burden, social support, and quality of life. To determine the effectiveness of the FIDD program, knowledge of mental illness and problem-solving skills are assessed in the families following treatment.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Have schizophrenia, schizoaffective disorder, or bipolar disorder
  • Have a current substance use disorder (within the past 6 months)
  • Are willing to have at least 4 hours of contact per week with family members or significant others
  • Plan to remain in the community
  • Have family members or significant others who consent to participate in the study and plan to remain in the community
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00043693

Locations
United States, California
Pacific Clinics El Camino
Santa Fe Springs, California, United States, 90670-3691
United States, Massachusetts
North Suffolk Mental Health Association
Chelsea, Massachusetts, United States, 02150
Sponsors and Collaborators
Investigators
Principal Investigator: Kim T. Mueser, PhD Dartmouth-Hitchcock Medical Center
Principal Investigator: Shirley Glynn, PhD University of California, Los Angeles
  More Information

Publications:
Responsible Party: Dartmouth Medical School ( Kim T. Mueser, PhD )
Study ID Numbers: R01 MH62629, DSIR SE-CE
Study First Received: August 12, 2002
Last Updated: September 29, 2008
ClinicalTrials.gov Identifier: NCT00043693  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Psychotic Disorders
Schizoaffective Disorder
Substance Abuse

Study placed in the following topic categories:
Schizophrenia
Affective Disorders, Psychotic
Mental Disorders
Bipolar Disorder
Mood Disorders
Substance-Related Disorders
Disorders of Environmental Origin
Psychotic Disorders
Schizophrenia and Disorders with Psychotic Features

Additional relevant MeSH terms:
Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 13, 2009